Glenn Francis

7.6k total citations
38 papers, 1.1k citations indexed

About

Glenn Francis is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Glenn Francis has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Glenn Francis's work include HER2/EGFR in Cancer Research (15 papers), AI in cancer detection (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Glenn Francis is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), AI in cancer detection (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Glenn Francis collaborates with scholars based in Australia, United States and Canada. Glenn Francis's co-authors include Sandra Stein, Ali Naderi, Ji Liu, Kee Ming Chia, Søren Nielsen, Paul E. Swanson, Merdol Ibrahim, Emina Torlakovic, Clive R. Taylor and Mogens Vyberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Glenn Francis

36 papers receiving 1.1k citations

Peers

Glenn Francis
Susan Fineberg United States
Mary Falzon United Kingdom
Ching Ouyang United States
David Dearnaley United Kingdom
Susan Fineberg United States
Glenn Francis
Citations per year, relative to Glenn Francis Glenn Francis (= 1×) peers Susan Fineberg

Countries citing papers authored by Glenn Francis

Since Specialization
Citations

This map shows the geographic impact of Glenn Francis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Francis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Francis more than expected).

Fields of papers citing papers by Glenn Francis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Francis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Francis. The network helps show where Glenn Francis may publish in the future.

Co-authorship network of co-authors of Glenn Francis

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Francis. A scholar is included among the top collaborators of Glenn Francis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Francis. Glenn Francis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Francis, Glenn, et al.. (2025). Emerging roles of FTIR spectroscopy in toxic metal profiling: innovations for food safety monitoring. SHILAP Revista de lepidopterología. 12(1).
2.
Kumarasinghe, M. Priyanthi, Adrienne Morey, Michael Bilous, et al.. (2017). HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program. Pathology. 49(6). 575–581. 10 indexed citations
3.
Torlakovic, Emina, Carol C. Cheung, Corrado D’Arrigo, et al.. (2017). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine – Part 2: Immunohistochemistry Test Performance Characteristics. Applied immunohistochemistry & molecular morphology. 25(2). 79–85. 28 indexed citations
4.
Cheung, Carol C., Corrado D’Arrigo, Manfred Dietel, et al.. (2016). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers. Applied immunohistochemistry & molecular morphology. 25(1). 4–11. 30 indexed citations
5.
Cheung, Carol C., Corrado D’Arrigo, Manfred Dietel, et al.. (2016). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 25(4). 227–230. 18 indexed citations
6.
Torlakovic, Emina, Søren Nielsen, Glenn Francis, et al.. (2014). Standardization of Positive Controls in Diagnostic Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 23(1). 1–18. 66 indexed citations
7.
Torlakovic, Emina, Glenn Francis, J. R. Garratt, et al.. (2014). Standardization of Negative Controls in Diagnostic Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 22(4). 241–252. 70 indexed citations
9.
Fox, Stephen B., M. Priyanthi Kumarasinghe, Jane E. Armes, et al.. (2012). Gastric HER2 Testing Study (GaTHER). The American Journal of Surgical Pathology. 36(4). 577–582. 35 indexed citations
10.
Quan, Jingjing, Chuan‐Xiang Zhou, Newell W. Johnson, et al.. (2012). Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. Pathology. 44(3). 221–227. 20 indexed citations
11.
Bilous, Michael, Adrienne Morey, Jane E. Armes, et al.. (2012). Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program. Breast Cancer Research and Treatment. 134(2). 617–624. 28 indexed citations
12.
Nicholls, John M. & Glenn Francis. (2011). Anatomical pathology is dead? Long live anatomical pathology. Pathology. 43(6). 635–641. 2 indexed citations
13.
Naderi, Ali, Ji Liu, & Glenn Francis. (2011). A feedback loop between BEX2 and ErbB2 mediated by c‐Jun signaling in breast cancer. International Journal of Cancer. 130(1). 71–82. 15 indexed citations
14.
Brown, Melissa A., Juliet D. French, Susan Edwards, et al.. (2010). Identification of novel biomarkers for breast cancer, including brca1-associated breast cancer. Queensland's institutional digital repository (The University of Queensland). 3 indexed citations
15.
Farshid, Gelareh, Jane E. Armes, Richard H. Bell, et al.. (2010). Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer. Diagnostic Molecular Pathology. 19(4). 187–193. 11 indexed citations
16.
Austin, Rachel, Bridie S. Thompson, Michael Coory, et al.. (2009). Histopathology reporting of breast cancer in Queensland: the impact on the quality of reporting as a result of the introduction of recommendations. Pathology. 41(4). 361–365. 25 indexed citations
17.
Thompson, Bridie S., Rachel Austin, Michael Coory, et al.. (2008). Completeness of Histopathology Reporting of Melanoma in a High-Incidence Geographical Region. Dermatology. 218(1). 7–14. 10 indexed citations
18.
Bilous, Michael, Adrienne Morey, Jane E. Armes, Margaret C. Cummings, & Glenn Francis. (2006). Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology. 38(2). 120–124. 32 indexed citations
19.
Jeffery, Penny L., et al.. (2005). Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocrine Related Cancer. 12(4). 839–850. 83 indexed citations
20.
Francis, Glenn, et al.. (2000). Whiplash rove beetle dermatitis in central Queensland. Australasian Journal of Dermatology. 41(3). 162–167. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026